45
Participants
Start Date
October 18, 2016
Primary Completion Date
July 24, 2017
Study Completion Date
July 24, 2017
BMS-931699
Specified dose on specified days
BMS-986142
Specified dose on specified days
Placebo
Specified dose on specified days
Local Institution, Lima Cercado
Local Institution, Camperdown
Local Institution, Stellenbosch
Local Institution, Mineola
Local Institution, Mexico City
Local Institution, Wexford
Local Institution, Philadelphia
Pmg Research Of Wilmington Llc, Wilmington
Acme Research, Llc, Orangeburg
North Georgia Rheumatology Group, Lawrenceville
Local Institution, Sarasota
West Tennessee Research Institute, Jackson
Local Institution, Tupelo
Paramount Medical Research & Consulting, Llc, Middleburg Heights
Local Institution, Guadalajara
Azienda Ospedaliera Universitaria Pisana, Pisa
Tekton Research Inc, Austin
New Mexico Clinical Research & Osteoporosis Center, Albuquerque
Local Institution, Veracruz
St Joseph Heritage Healthcare, Fullerton
Local Institution, Palo Alto
Local Institution, Mérida
Local Institution, Moscow
Local Institution, Santiago
Clinical Pharmacology Study Group, Worcester
Arthritis And Osteoporosis Associates, Pa, Freehold
Altoona Center For Clinical Research, Duncansville
Local Institution, Bogota
Local Institution, Bogotá
Local Institution, Santiago de Cali
Local Institution, Lima
Instituto De Ginecologia Y Reproduccion Inv. Clinical Sac, Lima
Klinika Reumatologii i Chorob Wewnetrznych, Wroclaw
Local Institution, San Juan
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY